Our Doctors

Dr. Abraham Schwarzberg

Abraham Schwarzberg, MD

Senior Vice President of Network
Development & Chief of Oncology,
Tampa General Hospital

Abraham Schwarzberg, MD, formerly a clinical instructor of medicine at Harvard Medical School and staff physician at Massachusetts General Hospital’s department of medical oncology, has an ongoing commitment to academic medicine and clinical research. Dr. Schwarzberg received his medical oncology and hematology training at Dana-Farber Cancer Institute and his internal medicine training at Brigham & Women’s Hospital, both in Boston.

Dr. Schwarzberg is the Senior Vice President of Network Development & Chief of Oncology at Tampa General Hospital. He is a member of the American Society of Clinical Oncology.

BOARD CERTIFICATIONS
Internal Medicine
Medical Oncology
Hematology

CANCER CARE SPECIALTIES
Bladder
Genitourinary
Melanoma
Prostate

HOSPITAL STAFF PRIVILEGES
Jupiter Medical Center (Jupiter, Florida)
JFK Medical Center — Main Campus (Atlantis, Florida)
Palm Beach Gardens Medical Center
(Palm Beach Gardens, Florida)

MEDICAL SCHOOL
George Washington University School of Medicine
(Washington, D.C.)

INTERNSHIP
Brigham & Women’s Hospital
(Boston, Massachusetts), Internal Medicine

RESIDENCY
Brigham & Women’s Hospital (Boston, Massachusetts)

FELLOWSHIP
Dana-Farber Cancer Institute (Boston, Massachusetts),
Hematology and Medical Oncology

Talya Schwarzberg

Talya Schwarzberg, MD

Medical Oncologist

Talya Schwarzberg, MD, is a former clinical instructor of medicine at Harvard Medical School and staff physician at Massachusetts General Hospital’s department of medical oncology. She received her medical oncology and hematology training at Beth Israel Deaconess Medical Center and her internal medicine training at Brigham & Women’s Hospital, both in Boston.

Dr. Schwarzberg is currently seeing patients with different types of cancers, with a focus on breast and gynecologic cancers. She is a member of the American Society of Clinical Oncology.

BOARD CERTIFICATIONS
Internal Medicine
Medical Oncology

CANCER CARE SPECIALTIES
Breast
Gynecologic Cancers

HOSPITAL STAFF PRIVILEGES
Jupiter Medical Center (Jupiter, Florida)
JFK Medical Center — Main Campus
(West Palm Beach, Florida)
Palm Beach Gardens Medical Center
(Palm Beach Gardens, Florida)

MEDICAL SCHOOL
SUNY Upstate Medical University
(Syracuse, New York)
George Washington University School of Medicine
(Washington, D.C.)

INTERNSHIP
Brigham & Women’s Hospital (Boston, Massachusetts)

RESIDENCY
Brigham & Women’s Hospital (Boston, Massachusetts)

FELLOWSHIP
Beth Israel Deaconess Medical Center (Boston,
Massachusetts), Hematology and Medical Oncology

Raymond Tsao, MD

Raymond Tsao, MD

Medical Oncologist

Before joining the Tampa General Hospital Cancer Institute, Raymond Tsao, MD, served as an assistant professor at the University of North Carolina, where his duties included cancer care, medical education and enrolling patients in clinical trials. His research on pancreatic cancer and lymphoma has been published and presented during national cancer meetings. Dr. Tsao completed his fellowship in hematology and medical oncology at The Cleveland Clinic Foundation in Cleveland, and has been a member of multiple national cancer research organizations, including Southwest Oncology Group and National Surgical Adjuvant Breast and Bowel Project.

Dr. Tsao is board certified in medical oncology and hematology. He is currently seeing patients with all types of cancer, with a focus on hematologic and gastrointestinal malignancies, including esophageal, stomach, colorectal and pancreatic cancer. Dr. Tsao is a member of the American Society of Clinical Oncology and American Society of Hematology.

BOARD CERTIFICATIONS
Hematology
Internal Medicine
Medical Oncology

CANCER CARE SPECIALTIES
Gastrointestinal
Hematology

HOSPITAL STAFF PRIVILEGES
Jupiter Medical Center (Jupiter, Florida)
JFK Medical Center — Main Campus (Atlantis, Florida)
Palm Beach Gardens Medical Center
(Palm Beach Gardens, Florida)

MEDICAL SCHOOL
Robert Wood Johnson Medical School
(Camden, New Jersey)

INTERNSHIP
Brown University (Providence, Rhode Island),
Internal Medicine

RESIDENCY
Brown University (Providence, Rhode Island),
Internal Medicine

FELLOWSHIP
The Cleveland Clinic Foundation (Cleveland, Ohio),
Hematology and Medical Oncology

Sujal Shah, MD

Sujal Shah, MD

Medical Oncologist

Sujal Shah, MD is a former assistant professor of medicine at the University of Texas at Austin and an associate instructor of clinical medicine at Geisel School of Medicine at Dartmouth in Hanover, New Hampshire. Dr. Shah completed his internal medicine residency and his hematology and oncology fellowship at Tulane University Hospital and Clinics in New Orleans.

Dr. Shah is currently seeing patients with different types of cancers, with a focus on lung cancer and head and neck cancers. Dr. Shah is a member of the American Society of Clinical Oncology and the American Society of Hematology.

BOARD CERTIFICATIONS
Internal Medicine
Medical Oncology

CANCER CARE SPECIALTIES
Head and Neck
Lung

HOSPITAL STAFF PRIVILEGES
Jupiter Medical Center
(Jupiter, Florida)
JFK Medical Center — Main Campus
(Atlantis, Florida)
Palm Beach Gardens Medical Center
(Palm Beach Gardens, Florida)

MEDICAL SCHOOL
Rush University Medical College (Chicago, Illinois)

POSTDOCTORAL TRAINING
Tulane University Hospital and Clinics
(New Orleans, Louisiana), Department of Medicine

RESIDENCY
Tulane University Hospital and Clinics
(New Orleans, Louisiana), Internal Medicine

FELLOWSHIP
Tulane University Hospital and Clinics
(New Orleans, Louisiana),
Hematology and Oncology

Vijay Narendran, MD, MBA
Vijay Narendran, MD, MBA

Medical Oncologist

Dr. Vijay Narendran, MD, MBA, trained in internal medicine at University Hospitals Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center in Cleveland. Dr. Narendran continued his graduate medical studies at New York University School of Medicine by pursuing a clinical fellowship in hematology and medical oncology. Dr. Narendran later conducted research in hematologic malignancies and went on to become an assistant professor at Hofstra University School of Medicine in Hempstead, New York. Dr. Narendran also worked at Monter Cancer Center in North New Hyde Park, New York, focusing on hematologic malignancies such as leukemia and lymphoma, and a variety of benign blood disorders. Before joining the Tampa General Hospital Cancer Institute, Dr. Narendran also practiced medicine in the Pacific Northwest, working primarily in cancers of the lung, and the head and neck.

Dr. Narendran treats a variety of cancers and has a special interest in gastrointestinal and hematologic malignancies. Dr. Narendran is a member of the American Society of Clinical Oncology and the American Society of Hematology.

BOARD CERTIFICATIONS
Hematology
Medical Oncology

CANCER CARE SPECIALTIES
Gastrointestinal
Hematology

HOSPITAL STAFF PRIVILEGES
Jupiter Medical Center (Jupiter, Florida)
JFK Medical Center — Main Campus (Atlantis, Florida)
Palm Beach Gardens Medical Center
(Palm Beach Gardens, Florida)

MEDICAL SCHOOL
Texas Tech University Health Sciences Center
School of Medicine (Lubbock, Texas)

INTERNSHIP
Case Western Reserve University School of Medicine
(Cleveland, Ohio), Internal Medicine

RESIDENCY
Case Western Reserve University School of Medicine
(Cleveland, Ohio), Internal Medicine

FELLOWSHIP
New York University School of Medicine
(New York, New York), Hematology and Medical Oncology

Mayer Fishman, MD, PHD

Mayer Fishman, MD, PHD

Medical Oncologist

Mayer Fishman, MD, PhD, has more than 20 years of experience in medical oncology, specializing in urologic oncology. With a focus on creating longitudinal plans for patient care, Dr. Fishman utilizes emerging therapies and medication options to coordinate chemotherapy, medical therapy, radiation and surgical services. Dr. Fishman provides second opinions, consultations and treatments for:

Kidney cancer • Bladder cancer • Prostate cancer • Penile cancer • Testicular cancer • Urethral cancer

Dr. Fishman’s expertise in innovative care is matched by his teaching and administrative experience. In addition to spending more than 18 years on the medical staff and in different committees at H. Lee Moffitt Cancer Center in Tampa, Florida, he also served as a professor in the Department of Internal Medicine at USF Health Morsani College of Medicine in Tampa. Over 80 fellows have rotated through his clinic.

Dr. Fishman has more than 100 publications to his credit and has been invited to speak on a variety of oncology topics at lectures and seminars. He is a current member of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO) and American Association for Cancer Research (AACR).

BOARD CERTIFICATIONS
Internal Medicine
Medical Oncology

TRAINING
Medical School:
University of Maryland School of Medicine
(Baltimore, Maryland)

RESIDENCY
Internal Medicine
Washington University School of Medicine
(St. Louis, Missouri)

FELLOWSHIP
Medical Oncology and Hematology
H. Lee Moffitt Cancer Center and USF Health
Morsani College of Medicine
(Tampa, Florida)

Eduardo M. Sotomayor, MD

Eduardo M. Sotomayor, MD

Director, Cancer Institute
Tampa General Hospital

Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences.

Dr. Sotomayor has returned to Tampa, where he previously had a highly productive 15-year tenure with Moffitt Cancer Center. He served as the Susan and John Sykes Endowed Chair of Hematologic Malignancies and chair of the department of malignant hematology. In addition, he was the scientific director of the DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center. He also guided future medical professionals as a professor in the University of South Florida College of Medicine’s departments of oncologic sciences, and pathology and cell biology.

BOARD CERTIFICATIONS
American Board of Internal Medicine, Medical Oncology

CONDITIONS TREATED
Lymphomas and lymphoproliferative disorders
Leukemias

PROCEDURES OFFERED
Cell therapies (CAR T-cells) (in the near future)

MEDICAL SCHOOL
Federico Villarreal National University School of Medicine
(Lima, Peru)

RESIDENCY
Jackson Memorial Medical Center, University of Miami School of Medicine
(Miami, FL)

FELLOWSHIP
Medical Oncology
Johns Hopkins University School of Medicine (Baltimore, MD)

Cancer Immunology Research
Department of Microbiology & Immunology
University of Miami School of Medicine
(Miami, FL)

Dr David Swoboda
David M. Swoboda, MD

Dr. David Swoboda is a hematologist oncologist at Tampa General Hospital who specializes in malignant hematology. Prior to joining Tampa General, he was a chief hematology-oncology fellow at H. Lee Moffitt Cancer Center in Tampa after serving as a chief resident at Medstar Georgetown University Hospital in Washington, D.C. Dr. Swoboda received his medical degree from Florida State University College of Medicine in Tallahassee, where he was the president of the Internal Medicine Interest Group.

Dr. Swoboda enjoys developing a close relationship with his patients and their families, building trust and gaining a full understanding of each disease in order to provide personalized, comprehensive care. His research is directed toward acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative disorders. He has published several entries in peer-reviewed journals and has participated in numerous scientific abstract presentations. Dr. Swoboda has memberships with the Society for Hematology Oncology, American Society of Hematology and American Society of Clinical Oncology.

BOARD CERTIFICATIONS
American Board of Internal Medicine

CONDITIONS TREATED
Acute myeloid leukemia
Myelodysplastic syndromes and myeloproliferative disorders
Acute lymphoblastic leukemia and lymphomas

PROCEDURES OFFERED
Cell therapies (CAR T-cells) (in the near future)

MEDICAL SCHOOL
Florida State University College of Medicine
(Tallahassee, Fla.)

RESIDENCY
Chief Resident, Internal Medicine
Medstar Georgetown University Hospital (Washington, D.C.)

FELLOWSHIPS
Chief Fellow, Hematology/Oncology
H. Lee Moffitt Cancer Center and Research Institute (Tampa, Fla.)

Dr. Jamie E. McKenzie
Jamie E. McKenzie, MD

Dr. Jamie McKenzie is a hematologist-oncologist at Tampa General Hospital who specializes in breast cancer. She is a compassionate physician who utilizes a multidisciplinary approach to providing patients with comprehensive care and rehabilitation before and throughout the treatment process. Prior to joining Tampa General Hospital, she had a clinical practice with New England Cancer Specialists at community sites in Maine and New Hampshire. Dr. McKenzie also was a presenter and Breast Cancer Tumor Board participant at Portsmouth Regional Hospital in New Hampshire.

In addition to practicing medicine, Dr. McKenzie has followed her passion for educating patients and instructing future professionals around the world throughout her medical career. While working as a hematologist and medical oncologist at Lahey Medical Center in Massachusetts, she participated in the multidisciplinary breast cancer clinic and also served as an internal medicine resident teacher. Years before, she was a teaching assistant for doctor-patient communication and physical diagnosis at Drexel University College of Medicine in Philadelphia, where she graduated with honors. Following post-graduate training, Dr. McKenzie began her career as a hematologist and medical oncologist in Washington state with Providence Regional Cancer System in 2013.

Dr. McKenzie is board certified in medical oncology, hematology, hospice and palliative medicine and internal medicine. She is a current member of the American Society of Clinical Oncology. She has a particular interest in the care of young women with breast cancer and the role that lifestyle factors/modification play in the prevention and management of breast cancer.

BOARD CERTIFICATIONS
American Board of Internal Medicine – Medical Oncology, Hematology, Hospice and Palliative
Medicine, Internal Medicine

CONDITIONS TREATED
Breast Cancer

TREATMENT OPTIONS
Endocrine therapy
Chemotherapy
Immunotherapy
Targeted therapy

MEDICAL SCHOOL
Drexel University College of Medicine
(Philadelphia, Pa.)

RESIDENCY
Internal Medicine
Massachusetts General Hospital
(Boston, Mass.)

FELLOWSHIPS
Hematology-Oncology
Beth Israel Deaconess Medical Center
(Boston, Mass.)

Palliative Medicine
Harvard University: Massachusetts General Hospital and Dana-Farber Cancer Institute
(Boston, Mass.)

Dr. Alan Kerr
D. Alan Kerr II, MD, PHD

Dr. D. Alan Kerr is a hematologist-oncologist and physician scientist with Tampa General Hospital, where he previously conducted continuity clinic work with a focus on malignant hematology. He specializes in benign and malignant hematology as well as solid tumor oncology.

Prior to joining Tampa General, Dr. Kerr treated patients in a private community practice at Advanced Cancer Treatment Centers (ACTC) in Brooksville, Fla., after completing a three-year hematology and medical oncology fellowship program with Moffitt Cancer Center/University of South Florida. Before that, he completed an internal medicine residency program at the University of Louisville in Kentucky, where he served as a chief medical resident. In the same department, he followed his passion for teaching future medical professionals as an assistant professor from 2015-16. Dr. Kerr received his medical degree from the University of Louisville School of Medicine and holds a Ph.D. in biochemistry and molecular biology from the University of Louisville.

Dr. Kerr is a site investigator for numerous active clinical trials and his primary clinical interests include lymphomas and myeloid diseases. Well-versed in translational research and clinical research protocols, Dr. Kerr is credited with several publications, oral presentations and abstracts on a wide range of oncology topics. He is a diplomat of the American Board of Internal Medicine and has memberships with the American Society of Clinical Oncology and the American Society of Hematology.

BOARD CERTIFICATIONS
American Board of Internal Medicine – Internal Medicine, Hematology, Medical Oncology

CONDITIONS TREATED
Anemia
Blood clotting/bleeding disorders

CANCERS
Leukemia
Lymphoma
Myeloma
Solid tumors

PROCEDURES OFFERED
Bone marrow biopsies
Intrathecal chemo infusions

MEDICAL SCHOOL
University of Louisville School of Medicine (Louisville, Ky.)

GRADUATE SCHOOL
University of Louisville (Louisville, Ky.)

RESIDENCY
Internal Medicine
University of Louisville (Louisville, Ky.)

FELLOWSHIPS
Hematology and Medical Oncology
Moffitt Cancer Center/University of South Florida (Tampa, Fla.)

Tulika Ranjan, MD
Tulika Ranjan, MD

Dr. Tulika Ranjan is a renowned neuro-oncologist with the Cancer Institute at Tampa General Hospital. She has a wealth of experience in treating adult primary brain and spinal cord tumors and has conducted groundbreaking research on new therapies for treating glioblastoma (GBM).

Prior to joining Tampa General Hospital, Dr. Ranjan was the director of the Allegheny Health Network (AHN) adult neuro-oncology program that specialized in advanced modalities such as laser interstitial thermal therapy and cancer stem cell chemo-sensitivity testing. She also served as chairperson for AHN Cancer Institute Neurologic-Oncology disease site leadership team.

Before joining AHN in 2015, Dr. Ranjan was part of the collaborative clinical research team at Duke University’s Preston Robert Tisch Brain Tumor Center that developed a novel therapy using the polio virus to treat GMB, a highly aggressive form of brain cancer.

Dr. Ranjan’s prominent clinical trials include “Chemo ID for GBM,” which was a multicenter trial run at the national level. Her Executive General Management program education from Harvard University, further supports innovations and cost-effective management in the health care field.

BOARD CERTIFICATIONS
Neuro-Oncology, American Board of Psychiatry and Neurology

CONDITIONS TREATED
Cancer:
Brain cancer • Brain metastases • Glioblastoma • Leptomeningeal disease • Primary central nervous system (CNS) lymphoma

Benign:
Ependymoma • Low-grade glial tumor • Meningioma • Schwannoma

TREATMENTS OFFERED
Chemotherapy • Clinical trials • Immunotherapy • Ommaya/intrathecal treatment • Optune device • Targeted therapy

MEDICAL SCHOOL
Sri Krishna Medical College (India)

RESIDENCY
Neurology and Medicine
Rutgers University (Newark, N.J.)

FELLOWSHIPS
Neuro-Oncology
Memorial Sloan Kettering Cancer Center (New York City, N.Y.)

GENERAL MANAGEMENT PROGRAM
Harvard Business School (HBS) (Boston, Mass.)

Kelly Foster MD
Kelly Foster, MD

Kelly Foster, MD, is a former medical oncologist at Northwestern Medicine in Chicago, where she provided quality care to patients with all types of cancer. Dr. Foster completed her internal medicine residency and her medical oncology and palliative medicine fellowship training all at Northwestern University. She received her undergraduate degree at UCLA and completed medical school at Loyola University Chicago.

Dr. Foster is board certified in medical oncology, internal medicine and palliative medicine. She is currently seeing patients with all types of cancer, with a focus on breast and gastrointestinal cancers (gastric, esophageal, pancreatic, hepatobiliary, colon, anal). She is a member of the American Society of Clinical Oncology.

BOARD CERTIFICATIONS
Medical Oncology
Hospice and Palliative Medicine
Internal Medicine

CANCER CARE SPECIALTIES
Breast cancer
Gastrointestinal cancers (gastric, esophageal, pancreatic, hepatobiliary, colon, anal)

HOSPITAL STAFF PRIVILEGES
Jupiter Medical Center (Jupiter, Fla.)
JFK Medical Center — Main Campus (Atlantis, Fla.)
Palm Beach Gardens Medical Center (Palm Beach Gardens, Fla.)

MEDICAL SCHOOL
Loyola University Chicago Stritch School of Medicine (Maywood, Ill.)

INTERNSHIP
Northwestern University (Chicago, Ill.)

RESIDENCY
Northwestern University (Chicago, Ill.)

FELLOWSHIP
Northwestern University (Chicago, Ill.)
Medical Oncology and Palliative Medicine

Norman Ashraf
Noman Ashraf, MD

Dr. Noman Ashraf is a hematologist-oncologist with Tampa General Hospital who specializes in solid tumor oncology. He has been an Associate Professor of Medicine in the Division of Hematology/Oncology at the USF Health Morsani College of Medicine since 2019. Additionally, he has been actively involved with the Hematology and Medical Oncology Fellowship Program at the USF Health Morsani College of Medicine and Moffitt Cancer Center.

Prior to joining Tampa General, Dr. Ashraf served as the assistant chief of the Division of Hematology/Oncology at James A. Haley Veterans’ Hospital in Tampa after completing his hematology and medical oncology fellowship with USF Health Morsani College of Medicine and Moffitt Cancer Center in 2012. He completed his internal medicine residency at Baylor College of Medicine in Houston and received his medical degree with honors from The Aga Khan University in Pakistan.

Dr. Ashraf has been an invited speaker and presenter at regional, national and international conferences, including many throughout Tampa. He has formally trained more than 80 post-graduate fellows, including many current TGH medical staff members. Dr. Ashraf has also served as a principal investigator for clinical trials and is credited with several peer-reviewed publications, book chapters, and presentations in his areas of expertise.

Victoria Rizk

Victoria Rizk, MD

Dr. Victoria Rizk is a board-certified medical oncologist who specializes in the care and treatment of patients with breast cancer. Prior to joining Tampa General Hospital Cancer Institute, Dr. Rizk worked as a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City, where she provided comprehensive care, support, and education for patients with breast cancer. Additionally, she was as an instructor in medicine at Weill Medical College of Cornell University, where she taught and mentored medical students. Aspiring to become an oncologist from a young age, Dr. Rizk graduated from an accelerated, six-year B.A./M.D. program at the University of Missouri-Kansas City School of Medicine. She then completed Internal Medicine Residency at the University of South Florida Morsani College of Medicine and Hematology/Oncology Fellowship at the University of South Florida/Moffitt Cancer Center in Tampa.

Skilled in clinical research, Dr. Rizk is credited with several peer-reviewed publications, abstracts and presentations. She has received numerous honors, including the Merit Award from the Conquer Cancer Foundation and induction into the Gold Humanism Honor Society at the UMKC School of Medicine. Dr. Rizk has memberships with the American Society of Clinical Oncology, the European Society for Medical Oncology, the American College of Physicians and the American Medical Association.

BOARD CERTIFICATIONS
American Board of Internal Medicine
Internal Medicine
Medical Oncology

CANCER CARE SPECIALTIES
Breast Cancer
Sarcoma

HOSPITAL STAFF PRIVILEGES
Tampa General Hospital
(Tampa, Florida)

MEDICAL SCHOOL
University of Missouri-Kansas City School of Medicine
(Kansas City, Missouri)

RESIDENCY
University of South Florida Morsani College of Medicine (Tampa, Florida),
Internal Medicine

FELLOWSHIP
University of South Florida/Moffitt Cancer Center (Tampa, Florida),
Hematology and Medical Oncology

Nikesh Shah, MD
Nikesh Shah, MD

Dr. Nikesh Shah is a hematologist/oncologist at Tampa General Hospital who specializes in hematologic malignancies, particularly lymphomas. Prior to joining Tampa General, Dr. Shah served as a chief fellow for the hematology/oncology fellowship program at Moffitt Cancer Center and the University of South Florida in Tampa. He completed the J. Willis Hurst Internal Medicine Residency Program at Emory University School of Medicine in Atlanta after receiving his medical degree from the University of Miami Leonard M. Miller School of Medicine in Miami, FL.

Dr. Shah is dedicated to developing close relationships with his patients and their families, providing them with a full understanding of each disease and determining the best personalized care for each patient. He enjoys conducting clinical research to identify the most cutting-edge treatment options available and has been credited with several peer-reviewed publications, presentations, abstracts, and book chapters in areas of his expertise.

Dr. Shah has memberships with the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, Florida Society of Clinical Oncology and the Florida Medical Association.

BOARD CERTIFICATIONS
American Board of Internal Medicine

CONDITIONS TREATED:
Acute lymphoblastic leukemia/lymphoma
Hematologic malignancies
Hodgkin lymphoma
Non-Hodgkin lymphoma

TREATMENTS OFFERED:
Cellular therapies (CAR-T, anticipated in 2023)
Chemotherapy
Immunotherapy
Intrathecal chemotherapy
Targeted therapy

MEDICAL SCHOOL
University of Miami Miller School of Medicine (Miami, FL)

RESIDENCY
Internal Medicine, Emory University (Atlanta, GA)

FELLOWSHIP
Chief Fellow, Hematology and Medical Oncology
H. Lee Moffitt Cancer Center and Research Institute (Tampa, FL)

Share This